1.
HIV infection: epidemiology, pathogenesis, treatment, and prevention
by Maartens, Gary, Prof
The Lancet (British edition), 2014, Vol.384 (9939), p.258-271
2.
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study
by Charlier, Caroline, Dr
The Lancet infectious diseases, 2017, Vol.17 (5), p.510-519
3.
Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy
by Rawlinson, William D, Prof
The Lancet infectious diseases, 2017, Vol.17 (6), p.e177-e188
4.
Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival
by Vironneau, P
Clinical microbiology and infection, 2014-05, Vol.20 (5), p.O336-O339
5.
Clinical features and viral diagnosis of two cases of infection with Middle East Respiratory Syndrome coronavirus: a report of nosocomial transmission
by Guery, Benoit, Prof Dr
The Lancet (British edition), 2013, Vol.381 (9885), p.2265-2272
6.
Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006
by TOWNSEND, Claire L
AIDS (London), 2008, Vol.22 (8), p.973-981
7.
Effectiveness of maternal pertussis vaccination in England: an observational study
by Amirthalingam, Gayatri, MFPH
The Lancet (British edition), 2014, Vol.384 (9953), p.1521-1528
8.
Estimating per-act HIV transmission risk: a systematic review
by Patel, Pragna
AIDS (London), 2014-06-19, Vol.28 (10), p.1509-1519
9.
Transformation of HIV from pandemic to low-endemic levels: a public health approach to combination prevention
by Jones, Alexandra, LLM
The Lancet (British edition), 2014, Vol.384 (9939), p.272-279
10.
Hospital organisation, management, and structure for prevention of health-care-associated infection: a systematic review and expert consensus
by Zingg, Walter, MD
The Lancet infectious diseases, 2015, Vol.15 (2), p.212-224
11.
Addendum guidelines for the prevention of peanut allergy in the United States: Report of the National Institute of Allergy and Infectious Diseases–sponsored expert panel
by Togias, Alkis, MD
Journal of allergy and clinical immunology, 2016, Vol.139 (1), p.29-44
12.
Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: an interrupted time series study and cluster randomised trial
by Derde, Lennie P G, MD
The Lancet infectious diseases, 2014, Vol.14 (1), p.31-39
13.
Attributable mortality of ventilator-associated pneumonia: a meta-analysis of individual patient data from randomised prevention studies
by Melsen, Wilhelmina G, Dr
The Lancet infectious diseases, 2013, Vol.13 (8), p.665-671
14.
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
by Smith, Colette J, Dr
The Lancet (British edition), 2014, Vol.384 (9939), p.241-248
15.
Nivolumab plus interferon-γ in the treatment of intractable mucormycosis
by Grimaldi, David
The Lancet infectious diseases, 2017, Vol.17 (1), p.18-18
16.
Why Sleep Is Important for Health: A Psychoneuroimmunology Perspective
by Irwin, Michael R
Annual review of psychology, 2015-01-03, Vol.66 (1), p.143-172
17.
Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis
by NACHEGA, Jean B
AIDS (London), 2012, Vol.26 (16), p.2039-2052
18.
Staphylococcus lugdunensis: a virulent pathogen causing bone and joint infections
by Douiri, N
Clinical microbiology and infection, 2016-08, Vol.22 (8), p.747-748
19.
Diagnostic point-of-care tests in resource-limited settings
by Drain, Paul K, Dr
The Lancet infectious diseases, 2014, Vol.14 (3), p.239-249
20.
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
by Nordmann, Patrice, MD
The Lancet infectious diseases, 2009, Vol.9 (4), p.228-236
